The FDA has received 185,702 adverse event reports for dogs that name Spinosad.
- 185,702 reports name Spinosad in dogs, which is 19% of all 1,001,380 dog reports. A report counts under every active ingredient it names.
- 10% are marked serious and 2.7% record a death or euthanasia; across all dog reports those figures are 29% and 5.4%.
- 22% are complaints that the product did not work (38% across all dog reports).
- The clinical signs reported most are emesis, vomiting and lethargy.
- The FDA lists 1 approved animal drug application containing Spinosad for dogs, the earliest approved in 2011.
- None of this is a rate. The FDA data does not record how many dogs were given Spinosad, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All dog reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 19,319 | 10% | 29% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 4,941 | 2.7% | 5.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 40,056 | 22% | 38% |
| Seizurea seizure or convulsion is among the clinical signs | 6,519 | 3.5% | 4.4% |
| Not used per labelthe report says the product was not used the way its label directs | 31,166 | 17% | 21% |
Where on the body do the reported signs sit?
Not on the body: Did not work 19% Whole body 11% How it was given 2.7%
- Stomach and gut53%emesis, vomiting, diarrhoea, anorexia and 3 more
- Did not work19%lack of efficacy (ectoparasite) - flea, lack of efficacy, ineffective, heartworm larvae, lack of efficacy (endoparasite) - heartworm and 1 more
- Whole body11%lethargy, death
- Brain and nerves6.5%seizure, ataxia, shaking, trembling
- Behaviour3.8%behavioural disorder, depression
- Skin and coat3.0%pruritus, itching
- How it was given2.7%unpalatable, overdose
- Blood and organ tests1.3%other abnormal test result
Each figure is a share of sign mentions among the 25 signs reported most for Spinosad in dogs. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Emesis55,390 30%
- Vomiting47,722 26%
- Lethargy22,310 12%
- Lack of efficacy (ectoparasite) - flea19,482 10%
- Lack of efficacy12,911 7.0%
- Diarrhoea8,676 4.7%
- INEFFECTIVE, HEARTWORM LARVAE5,668 3.0%
- Seizure5,344 2.9%
Reports received per year
Is it approved for dogs?
The FDA lists 1 approved animal drug application containing Spinosad for dogs, the earliest approved in 2011.
| Product | Form | Approved for | First approved | FDA application |
|---|---|---|---|---|
| TrifexisElanco US Inc. | Chewable Tablets RX | Dog | 2011 | 141-321 |
From the FDA record for Trifexis: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. Treatment with fewer than 3 monthly doses after the last exposure to mosquitos may not provide complete heartworm prevention. Use with caution in breeding females. The safe use of TRIFEXIS in breeding males has not been evaluated. Use with caution in dogs with pre-existing epilepsy.
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. See Spinosad in cats (11,875 reports). Open it in the lookup to set it beside another medicine, or read how the counts were collected.
- Milbemycin Oxime in dogs179,859
- Ivermectin in dogs168,964
- Pyrantel in dogs236,005
- Moxidectin in dogs76,891
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.